Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALLO Allogene Therapeutics Inc.

已收盘 08-15 16:00:00 EDT

2.30

+0.05

+2.22%

盘后2.35

+0.05+2.17%

19:27 EDT

最高2.41	最低2.24	成交量160.87万
今开2.30	昨收2.25	日振幅7.56%
总市值4.81亿	流通市值3.51亿	总股本2.09亿
成交额373.34万	换手率1.05%	流通股本1.53亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALLO","market":"US","secType":"STK","nameCN":"Allogene Therapeutics Inc.","latestPrice":2.3,"timestamp":1723752000000,"preClose":2.25,"halted":0,"volume":1608654,"hourTrading":{"tag":"盘后","latestPrice":2.35,"preClose":2.3,"latestTime":"19:27 EDT","volume":11921,"amount":27428.88,"timestamp":1723764438458},"delay":0,"floatShares":152546349,"shares":209111516,"eps":-1.60701,"marketStatus":"已收盘","marketStatusCode":5,"change":0.05,"latestTime":"08-15 16:00:00 EDT","open":2.3,"high":2.41,"low":2.24,"amount":3733435.6274376,"amplitude":0.075556,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.60701,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1723795200000},"adr":0,"listingDate":1539230400000,"adjPreClose":2.25,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.3,"preClose":2.25,"latestTime":"09:29 EDT","volume":1815,"amount":4165.6103115,"timestamp":1723728599925},"postHourTrading":{"tag":"盘后","latestPrice":2.35,"preClose":2.3,"latestTime":"19:27 EDT","volume":11921,"amount":27428.88,"timestamp":1723764438458},"volumeRatio":0.950502,"impliedVol":0.4701,"impliedVolPercentile":0.127},"requestUrl":"/m/hq/s/ALLO/wiki","defaultTab":"wiki","newsList":[{"id":"2459476723","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.24%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459476723","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459476723?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:41","pubTimestamp":1723732889,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时41分，Allogene Therapeutics, Inc.股票出现波动，股价快速拉升5.24%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522413098e350ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522413098e350ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","BK4139","ALLO"],"gpt_icon":0},{"id":"2459107470","title":"Allogene Therapeutics, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459107470","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459107470?lang=zh_cn&edition=full","pubTime":"2024-08-15 00:43","pubTimestamp":1723653805,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日00时43分，Allogene Therapeutics, Inc.股票出现波动，股价大幅下跌5.11%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815004325ab5db1b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815004325ab5db1b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALLO","BK4505"],"gpt_icon":0},{"id":"1174738584","title":"异动解读 | Allogene Therapeutics股价大涨 同种异体T细胞疗法前景受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1174738584","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174738584?lang=zh_cn&edition=full","pubTime":"2024-08-09 16:08","pubTimestamp":1723190883,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics Inc.今日股价大涨5.26%,报收2.60美元/股,引发市场广泛关注。作为一家专注于开发同种异体T细胞疗法的生物技术公司,Allogene的股价走势备受投资者关注。分析人士指出,Allogene的同种异体T细胞疗法前景广阔,有望成为癌症和自身免疫性疾病治疗的新方向。与传统的自体CAR-T疗法相比,同种异体T细胞疗法来自健康供体,可以更广泛地应用于患者,且具有更好的可扩展性。Allogene目前的产品线包括针对淋巴瘤、白血病、自身免疫性疾病和实体瘤的核心项目。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLO"],"gpt_icon":0},{"id":"2458441813","title":"美国研究综述-Amphastar Pharmaceuticals、G1 Therapeutics、Upwork","url":"https://stock-news.laohu8.com/highlight/detail?id=2458441813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458441813?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:55","pubTimestamp":1723136129,"startTime":"0","endTime":"0","summary":"    路透8月8日 - 华尔街证券分析师周四调整了对 Amphastar Pharmaceuticals、G1 Therapeutics 和 Upwork 等几家美国上市公司的评级和目标价。要点  * Amphastar Pharmaceuticals Inc   ：Piper Sandler 将目标价从 71 美元下调至 66 美元 * Charles River Laboratories International Inc   ：贝雅下调目标价至中性 * G1 Therapeutics Inc   ：H.C. Wainwright将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALB","CE","AIZ","BCSF","ARKO","ASLE","BLBD","LU2264538146.SGD","BYND","AGCO","CAR","BK4109","AZEK","BLNK","LU2430703095.HKD","APP","ALIT","IE00B19Z9P08.USD","AADI","LENZ","LU2430703251.USD","CELH","LU1244550577.SGD","ATEX","LU1599440770.SGD","ATGE","ACAD","ALLK","BK4107","LU0566484027.USD","BDSX","ASIX","AMPH","BWMN","BXSL","AEVA","ALLO","APLS","ADUS","BOOT","ALEX","AKA","TCPC","ASH","BLK","LU2430703178.SGD","ACM","AZPN","BARK","LU0823414478.USD"],"gpt_icon":1},{"id":"2457319251","title":"Allogene Therapeutics, Inc.盘中异动 早盘快速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457319251","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457319251?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:30","pubTimestamp":1723123827,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时30分，Allogene Therapeutics, Inc.股票出现异动，股价大幅上涨5.26%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.71%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408082130279682528f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408082130279682528f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","BK4139","ALLO"],"gpt_icon":0},{"id":"1129356240","title":"异动解读 | Allogene Therapeutics Inc.公布季度财报 股价盘中大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129356240","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129356240?lang=zh_cn&edition=full","pubTime":"2024-08-08 05:26","pubTimestamp":1723066009,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics Inc.今日盘中股价大跌5.10%,引发市场关注。根据最新公布的2024年第二季度财报,该公司调整后每股亏损35美分,与分析师预期持平。但营业收入为零,远低于分析师预期的1691万美元。财报显示,Allogene Therapeutics Inc.本季度亏损6636万美元。尽管如此,该公司股价今年迄今仍上涨9.4%,但较去年同期下跌20.6%。一些分析人士认为,Allogene Therapeutics Inc.本季度营收为零可能是导致股价下跌的主要原因。尽管亏损在预期范围内,但缺乏营收支撑或许令投资者对公司前景产生担忧,从而引发抛售潮。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLO"],"gpt_icon":0},{"id":"2457087318","title":"阿洛金治疗公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457087318","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457087318?lang=zh_cn&edition=full","pubTime":"2024-08-08 05:23","pubTimestamp":1723065791,"startTime":"0","endTime":"0","summary":"   * Allogene Therapeutics Inc   报告，截至6月底的季度调整后每股亏损35美分，高于去年同期的每股-53美分。17 位分析师对该季度的平均预期是每股亏损 35 美分。华尔街预期为每股-39美分至-28美分。* Allogene Therapeutics Inc 公布的本季度每股收益为亏损 35 美分。* 公司报告的季度亏损额为 6636 万美元。* Allogene Therapeutics Inc 本季度股价上涨了 9.4%，今年迄今为止亏损了 20.6%。8月7日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期上升了约 10.6%。华尔街对 Allogene Therapeutics Inc 的 12 个月目标价中位数为 9.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"阿洛金治疗公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLO","BK4505","BK4139"],"gpt_icon":0},{"id":"2457655844","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457655844","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457655844?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:31","pubTimestamp":1723037478,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时31分，Allogene Therapeutics, Inc.股票出现波动，股价大幅拉升5.10%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080721311896824c76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080721311896824c76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLO","LENZ","BK4505"],"gpt_icon":0},{"id":"2457058519","title":"Allogene Therapeutics Inc    预计每股亏损 35 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457058519","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457058519?lang=zh_cn&edition=full","pubTime":"2024-08-06 10:06","pubTimestamp":1722910001,"startTime":"0","endTime":"0","summary":"   * Allogene Therapeutics Inc    将于8月7日公布截至2024年6月30日的财报，预计季度收入将出现下降。* LSEG 分析师对 Allogene Therapeutics Inc 的平均预期是每股亏损 35 美分。* 目前分析师对该公司股票的平均评级为 \"买入\"，建议的细分为 13 个 \"强烈买入 \"或 \"买入\"，5 个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Allogene Therapeutics Inc 的 12 个月目标价中位数为 9.50 美元，高于其上次收盘价 2.49 美元。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ALLO"],"gpt_icon":0},{"id":"2457733937","title":"Allogene Therapeutics, Inc.盘中异动 早盘大幅下跌7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457733937","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457733937?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:39","pubTimestamp":1722865178,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时39分，Allogene Therapeutics, Inc.股票出现异动，股价急速跳水7.39%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.30%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052139389f107402&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052139389f107402&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALLO","BK4139","BK4505"],"gpt_icon":0},{"id":"2456343534","title":"Allogene Therapeutics, Inc.盘中异动 快速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456343534","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456343534?lang=zh_cn&edition=full","pubTime":"2024-08-01 22:36","pubTimestamp":1722523015,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日22时36分，Allogene Therapeutics, Inc.股票出现波动，股价快速下挫5.10%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801223655aefcb7e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801223655aefcb7e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALLO","BK4505"],"gpt_icon":0},{"id":"2455652129","title":"Allogene Therapeutics Inc    预计每股亏损 35 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455652129","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455652129?lang=zh_cn&edition=full","pubTime":"2024-07-29 20:38","pubTimestamp":1722256709,"startTime":"0","endTime":"0","summary":"   * Allogene Therapeutics Inc    预计将在7月31日公布截至2024年6月30日的业绩报告时显示季度收入下降(预计)。* 根据LSEG的数据，11位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司的营收预计将从一年前的4.4万美元下降61.6%，至1.691万美元。* LSEG 分析师对 Allogene Therapeutics Inc 的平均预期是每股亏损 35 美分。* 华尔街对 Allogene Therapeutics Inc 的 12 个月目标价中位数为 9.50 美元，高于其上一次收盘价 3.00 美元。7月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ALLO"],"gpt_icon":0},{"id":"2454831778","title":"Allogene Therapeutics, Inc.盘中异动 急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454831778","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454831778?lang=zh_cn&edition=full","pubTime":"2024-07-25 02:40","pubTimestamp":1721846430,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日02时40分，Allogene Therapeutics, Inc.股票出现异动，股价大幅下跌5.03%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725024030941fa353&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725024030941fa353&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLO","BK4505","LENZ"],"gpt_icon":0},{"id":"2453061395","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453061395","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453061395?lang=zh_cn&edition=full","pubTime":"2024-07-24 02:49","pubTimestamp":1721760578,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日02时49分，Allogene Therapeutics, Inc.股票出现波动，股价急速上涨5.36%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407240249389681f639&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407240249389681f639&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4505","ALLO"],"gpt_icon":0},{"id":"2452470611","title":"Allogene Therapeutics, Inc.盘中异动 早盘大幅下挫5.51%报2.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452470611","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452470611?lang=zh_cn&edition=full","pubTime":"2024-07-19 22:50","pubTimestamp":1721400657,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日22时50分，Allogene Therapeutics, Inc.股票出现异动，股价急速下挫5.51%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719225057aefa8bfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719225057aefa8bfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALLO","BK4139"],"gpt_icon":0},{"id":"2452487168","title":"Allogene Therapeutics, Inc.盘中异动 大幅下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452487168","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452487168?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:00","pubTimestamp":1721311215,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时00分，Allogene Therapeutics, Inc.股票出现异动，股价急速下挫5.23%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718220015941f8576&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718220015941f8576&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","BK4139","ALLO"],"gpt_icon":0},{"id":"2452157873","title":"Allogene Therapeutics, Inc.盘中异动 早盘快速跳水5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452157873","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452157873?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:32","pubTimestamp":1721223129,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时32分，Allogene Therapeutics, Inc.股票出现异动，股价快速跳水5.43%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213209aefa252f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213209aefa252f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","BK4139","ALLO"],"gpt_icon":0},{"id":"2451614990","title":"Allogene Therapeutics, Inc.盘中异动 早盘急速上涨5.37%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451614990","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451614990?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:30","pubTimestamp":1721136650,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时30分，Allogene Therapeutics, Inc.股票出现异动，股价急速上涨5.37%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716213050af9298eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716213050af9298eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALLO","BK4139","BK4505"],"gpt_icon":0},{"id":"2450495539","title":"Allogene Therapeutics, Inc.盘中异动 快速上涨5.22%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450495539","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450495539?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:16","pubTimestamp":1720793785,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时16分，Allogene Therapeutics, Inc.股票出现异动，股价大幅上涨5.22%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.46%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712221625aef97c37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712221625aef97c37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALLO","BK4139"],"gpt_icon":0},{"id":"2450368008","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.86%报2.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450368008","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450368008?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:30","pubTimestamp":1720704625,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时30分，Allogene Therapeutics, Inc.股票出现波动，股价大幅上涨5.86%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.43%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213025941f6408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213025941f6408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALLO","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allogene.com","stockEarnings":[{"period":"1week","weight":-0.0891},{"period":"1month","weight":-0.245},{"period":"3month","weight":-0.2525},{"period":"6month","weight":-0.5303},{"period":"1year","weight":-0.4485},{"period":"ytd","weight":-0.2991}],"compareEarnings":[{"period":"1week","weight":0.0484},{"period":"1month","weight":-0.0317},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0886},{"period":"1year","weight":0.2277},{"period":"ytd","weight":0.144}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Allogene Therapeutics, Inc.于2017年11月30日在特拉华州成立，总部位于加利福尼亚州南旧金山。该公司是一家临床阶段免疫肿瘤学公司，开创了用于治疗癌症的基因工程异体T细胞疗法的开发和商业化。公司正在开发一种现成的T细胞候选产品系列，旨在靶向和杀死癌细胞。Allogene Therapeutics, Inc.工程改造的T细胞是同种异体的，这意味着它们来自健康供体，用于任何患者，而不是来自患者的个体患者，如自体T细胞的情况。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.071404},{"month":2,"riseRate":0.666667,"avgChangeRate":0.050796},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.111126},{"month":4,"riseRate":0.5,"avgChangeRate":0.005289},{"month":5,"riseRate":0.166667,"avgChangeRate":0.032626},{"month":6,"riseRate":0.5,"avgChangeRate":0.040631},{"month":7,"riseRate":0.5,"avgChangeRate":0.041827},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.076175},{"month":9,"riseRate":0.6,"avgChangeRate":-0.052215},{"month":10,"riseRate":0.2,"avgChangeRate":-0.105941},{"month":11,"riseRate":0.333333,"avgChangeRate":0.009962},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.098907}],"exchange":"NASDAQ","name":"Allogene Therapeutics Inc.","nameEN":"Allogene Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Allogene Therapeutics Inc.(ALLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Allogene Therapeutics Inc.,ALLO,Allogene Therapeutics Inc.股票,Allogene Therapeutics Inc.股票老虎,Allogene Therapeutics Inc.股票老虎国际,Allogene Therapeutics Inc.行情,Allogene Therapeutics Inc.股票行情,Allogene Therapeutics Inc.股价,Allogene Therapeutics Inc.股市,Allogene Therapeutics Inc.股票价格,Allogene Therapeutics Inc.股票交易,Allogene Therapeutics Inc.股票购买,Allogene Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Allogene Therapeutics Inc.(ALLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}